Daptomycin as Adjunctive Therapy for Staphylococcus Aureus Bacteremia
Status:
Completed
Trial end date:
2019-09-01
Target enrollment:
Participant gender:
Summary
The purpose of our study is to examine the effects of a second antibiotic, daptomycin, in
combination with a beta lactam antibiotic on treating bloodstream infection caused by
methicillin-susceptible S. aureus.
Phase:
Phase 4
Details
Lead Sponsor:
McGill University Health Center McGill University Health Centre/Research Institute of the McGill University Health Centre